"Mupirocin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing.
- Pseudomonic Acid A
- Pseudomonic Acid
- Acid, Pseudomonic
Below are MeSH descriptors whose meaning is more general than "Mupirocin".
Below are MeSH descriptors whose meaning is more specific than "Mupirocin".
This graph shows the total number of publications written about "Mupirocin" by people in this website by year, and whether "Mupirocin" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Mupirocin" by people in Profiles.
Rubin LG, Beachy J, Matz T, Balamohan A, Jendresky L, Zembera J, Annavajhala MK, Uhlemann AC. Prolonged outbreak of clonal, mupirocin-resistant methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit: association with personnel and a possible environmental reservoir, analyzed using whole genome sequencing. Am J Infect Control. 2022 06; 50(6):680-685.
Levin LE, Shayegan LH, Lucky AW, Hook KP, Bruckner AL, Feinstein JA, Whittier S, Lauren CT, Pope E, Lara-Corrales I, Wiss K, McCuaig CC, Powell J, Eichenfield LF, Levy ML, Diaz L, Glick SA, Paller AS, Price HN, Browning JC, Morel KD. Characterization of wound microbes in epidermolysis bullosa: Results from the epidermolysis bullosa clinical characterization and outcomes database. Pediatr Dermatol. 2021 Jan; 38(1):119-124.